Editor's Pick “We are trying to be the first to build the quantum computer,” says Crow. "When we do it, and we will do it eventually, it’s going to be bigger than the moon landing.”
Nanotechnology is starting to pay off in materials that enable colorful liquid crystal displays.
Cambrios Technologies is announcing today that it has hired John LeMoncheck as its new chief executive and raised $5 million in a fourth round of funding from strategic investor Samsung Venture Investment.
The Sunnyvale, Calif.,-based company uses nanotechnology to create …
Researchers at the Department of Energy’s Argonne National Laboratory in Argonne, Ill., have found a way to assemble nanoparticles into larger structures, a technique that could accelerate the development of battery and bioenergy-based technologies.
Argonne biophysicist John Bahns said in …
Smart meter systems company Elster has filed for an IPO, offering 16.2 million initial shares that will be priced between $16 and $18. It is expected to net $152 million from the offering. As Green Tech Media notes, the …
TODAY’S HEADLINES:
Gelesis draws in $16M for obesity treatments (release)
Tempo Pharma raises $8B for nanoparticle drugs (release)
Calistoga Pharma receives additional $5M for cancer and inflammation drugs (release)
Montreux Equity Partners closes $250M life-sciences fund (release)
MTS Health Partners
…
NanoBioDesign, a London developer of systems that screen experimental drugs against key liver enzymes, raised $1 million (£500,000) to support manufacturing of its protein-chip devices. The funding was provided by the Imperial Innovations Group and the Capital Fund.
NanoBioDesign is …
Tempo Pharmaceuticals, a Cambridge, Mass., developer of new-drug formulations, raised $12.1 million in a first funding round. The company, which touts itself as a “nanopharmaceutical” maker, aims to improve the safety and effectiveness of existing drugs using engineered nanoparticles designed …
